Integra Lifesciences Holdings Stock Net Income
| IART Stock | USD 24.24 0.66 2.80% |
Integra LifeSciences Holdings fundamentals help investors to digest information that contributes to Integra LifeSciences' financial success or failures. It also enables traders to predict the movement of Integra Stock. The fundamental analysis module provides a way to measure Integra LifeSciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Integra LifeSciences stock.
| Last Reported | Projected for Next Year | ||
| Net Income | 67.7 M | 44.5 M | |
| Net Income Applicable To Common Shares | 207.6 M | 218 M | |
| Net Income From Continuing Ops | 67.7 M | 75.5 M | |
| Net Income Per Share | 0.87 | 0.91 | |
| Net Income Per E B T | 0.84 | 0.84 |
Integra | Net Income |
Integra LifeSciences Holdings Company Net Income Analysis
Integra LifeSciences' Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current Integra LifeSciences Net Income | 67.74 M |
Most of Integra LifeSciences' fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Integra LifeSciences Holdings is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Integra Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Integra LifeSciences is extremely important. It helps to project a fair market value of Integra Stock properly, considering its historical fundamentals such as Net Income. Since Integra LifeSciences' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Integra LifeSciences' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Integra LifeSciences' interrelated accounts and indicators.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Integra Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, Integra LifeSciences Holdings reported net income of 67.74 M. This is 80.15% lower than that of the Health Care Equipment & Supplies sector and 71.55% lower than that of the Health Care industry. The net income for all United States stocks is 88.14% higher than that of the company.
Integra Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Integra LifeSciences' direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Integra LifeSciences could also be used in its relative valuation, which is a method of valuing Integra LifeSciences by comparing valuation metrics of similar companies.Integra LifeSciences is currently under evaluation in net income category among its peers.
Integra LifeSciences ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Integra LifeSciences' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Integra LifeSciences' managers, analysts, and investors.Environmental | Governance | Social |
Integra LifeSciences Institutional Holders
Institutional Holdings refers to the ownership stake in Integra LifeSciences that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Integra LifeSciences' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Integra LifeSciences' value.| Shares | Capital Research Global Investors | 2024-09-30 | 1.3 M | Voloridge Investment Management, Llc | 2024-09-30 | 1.1 M | D. E. Shaw & Co Lp | 2024-09-30 | 1 M | Charles Schwab Investment Management Inc | 2024-09-30 | 944.3 K | Neuberger Berman Group Llc | 2024-06-30 | 828.5 K | Northern Trust Corp | 2024-09-30 | 812.3 K | Glenmede Trust Co Na | 2024-09-30 | 727.8 K | Lord, Abbett & Co Llc | 2024-09-30 | 713.3 K | Norges Bank | 2024-06-30 | 686.8 K | Blackrock Inc | 2024-06-30 | 11.3 M | Morgan Stanley - Brokerage Accounts | 2024-06-30 | 11 M |
Integra Fundamentals
| Return On Equity | -0.0042 | ||||
| Return On Asset | 0.0302 | ||||
| Profit Margin | (0) % | ||||
| Operating Margin | 0.07 % | ||||
| Current Valuation | 3.53 B | ||||
| Shares Outstanding | 77.16 M | ||||
| Shares Owned By Insiders | 3.21 % | ||||
| Shares Owned By Institutions | 93.27 % | ||||
| Number Of Shares Shorted | 5.18 M | ||||
| Price To Earning | 26.94 X | ||||
| Price To Book | 1.20 X | ||||
| Price To Sales | 1.16 X | ||||
| Revenue | 1.54 B | ||||
| Gross Profit | 982.03 M | ||||
| EBITDA | 383.57 M | ||||
| Net Income | 67.74 M | ||||
| Cash And Equivalents | 451.52 M | ||||
| Cash Per Share | 5.41 X | ||||
| Total Debt | 1.68 B | ||||
| Debt To Equity | 1.03 % | ||||
| Current Ratio | 3.85 X | ||||
| Book Value Per Share | 19.73 X | ||||
| Cash Flow From Operations | 139.96 M | ||||
| Short Ratio | 7.11 X | ||||
| Earnings Per Share | (0.09) X | ||||
| Price To Earnings To Growth | 0.79 X | ||||
| Target Price | 28.11 | ||||
| Number Of Employees | 3.95 K | ||||
| Beta | 1.08 | ||||
| Market Capitalization | 1.82 B | ||||
| Total Asset | 3.78 B | ||||
| Retained Earnings | 946.86 M | ||||
| Working Capital | 751.06 M | ||||
| Current Asset | 438.5 M | ||||
| Current Liabilities | 139.13 M | ||||
| Net Asset | 3.78 B |
About Integra LifeSciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Integra LifeSciences Holdings's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Integra LifeSciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Integra LifeSciences Holdings based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Integra Stock Analysis
When running Integra LifeSciences' price analysis, check to measure Integra LifeSciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Integra LifeSciences is operating at the current time. Most of Integra LifeSciences' value examination focuses on studying past and present price action to predict the probability of Integra LifeSciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Integra LifeSciences' price. Additionally, you may evaluate how the addition of Integra LifeSciences to your portfolios can decrease your overall portfolio volatility.